Patents by Inventor Patric Lundberg

Patric Lundberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Double-stranded and single-stranded RNA molecules with 5? triphosphates and their use for inducing interferon
    Patent number: 9938529
    Abstract: Double-stranded and single-stranded RNA molecules, and their use in methods for inducing interferon are provided. The interferon induction provides anti-viral and other medically useful effects, such as anti-cancer effects. Also provided are methods for reducing or inhibiting interferon induction exhibited by such molecules, particularly siRNA and shRNA molecules produced in vitro.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: April 10, 2018
    Assignee: City of Hope
    Inventors: John J. Rossi, Dongho Kim, Patric Lundberg, Edouard Cantin
  • DOUBLE-STRANDED AND SINGLE-STRANDED RNA MOLECULES WITH 5' TRIPHOSPHATES AND THEIR USE FOR INDUCING INTERFERON
    Publication number: 20160369280
    Abstract: Double-stranded and single-stranded RNA molecules, and their use in methods for inducing interferon are provided. The interferon induction provides anti-viral and other medically useful effects, such as anti-cancer effects. Also provided are methods for reducing or inhibiting interferon induction exhibited by such molecules, particularly siRNA and shRNA molecules produced in vitro.
    Type: Application
    Filed: September 2, 2016
    Publication date: December 22, 2016
    Applicant: CITY OF HOPE
    Inventors: John J. ROSSI, Dongho Kim, Patric Lundberg, Edouard Cantin
  • Double-stranded and single-stranded RNA molecules with 5? Triphosphates and their use for inducing interferon
    Patent number: 9434950
    Abstract: Double-stranded and single-stranded RNA molecules, and their use in methods for inducing interferon are provided. The interferon induction provides anti-viral and other medically useful effects, such as anti-cancer effects. Also provided are methods for reducing or inhibiting interferon induction exhibited by such molecules, particularly siRNA and shRNA molecules produced in vitro.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: September 6, 2016
    Assignee: CITY OF HOPE
    Inventors: John J. Rossi, Dongho Kim, Patric Lundberg, Edouard Cantin
  • DOUBLE-STRANDED AND SINGLE-STRANDED RNA MOLECULES WITH 5' TRIPHOSPHATES AND THEIR USE FOR INDUCING INTERFERON
    Publication number: 20150017722
    Abstract: Double-stranded and single-stranded RNA molecules, and their use in methods for inducing interferon are provided. The interferon induction provides anti-viral and other medically useful effects, such as anti-cancer effects. Also provided are methods for reducing or inhibiting interferon induction exhibited by such molecules, particularly siRNA and shRNA molecules produced in vitro.
    Type: Application
    Filed: July 29, 2014
    Publication date: January 15, 2015
    Applicant: CITY OF HOPE
    Inventors: John J. Rossi, Dongho Kim, Patric Lundberg, Edouard Cantin
  • Double-stranded and single-stranded RNA molecules with 5? triphosphates and their use for inducing interferon
    Patent number: 8791082
    Abstract: Double-stranded and single-stranded RNA molecules, and their use in methods for inducing interferon are provided. The interferon induction provides anti-viral and other medically useful effects, such as anti-cancer effects. Also provided are methods for reducing or inhibiting interferon induction exhibited by such molecules, particularly siRNA and shRNA molecules produced in vitro.
    Type: Grant
    Filed: September 21, 2007
    Date of Patent: July 29, 2014
    Assignee: City of Hope
    Inventors: John J. Rossi, Dongho Kim, Patric Lundberg, Edouard Cantin
  • COMPOSITIONS AND METHODS FOR TREATING HERPES SIMPLEX VIRUS INFECTIONS AND RELATED DISEASES
    Publication number: 20100040601
    Abstract: A method of treatment or prophylaxis of herpes infection and associated diseases by administration of compositions comprising pooled immunoglobulins. The active component of IVIG includes sialylated IgG species. Treatment and prophylaxis of herpes infection include herpes simplex virus 1 infection, its associated encephalitis and herpes stromal keratitis.
    Type: Application
    Filed: June 10, 2009
    Publication date: February 18, 2010
    Inventors: Edouard M. Cantin, Ramakrishna Chandran, Patric Lundberg